TPI News 0.95 Tianyin Pharmaceutical Co. (TPI)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Tianyin Pharmaceutical Co. (TPI) 0.95 $TPI

JCM Updates on Azithromycin API Export
PR Newswire - Wed Apr 16, 8:29PM CDT
Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the development and sale of patented biopharmaceutical medicine, modernized traditional Chinese medicine (TCM), branded generics, and active pharmaceutical ingredients (API), updated regarding the recent progress of the Jiangchuan Macrolide Facility (JCM). JCM has developed a new line of Azithromycin (Azi) API products that support steady monthly export orders to South Asia.

Health Care Stocks on our Radar -- Research on Novo Nordisk, Tianyin Pharma, Pernix Therapeutics Holdings, and Oculus Innovative Sciences
PR Newswire - Wed Mar 26, 12:10PM CDT
On Tuesday, March 25, 2014, the NASDAQ Composite finished at 4,234.27, up 0.19%. The Dow Jones Industrial Average closed the session at 16,367.88, up 0.56% and the S&P 500 ended the day at 1,865.62, higher by 0.44%. The gains were broad based with nine out of ten sectors ending the session in positive. The S&P 500 Health Care Sector Index finished the day at 671.69, up 0.83%, and the same has gained 5.27% in the previous three months. Investor-Edge has initiated coverage on the following equities: Novo Nordisk A/S (NYSE: NVO), Tianyin Pharmaceutical Co. Inc. (NYSE MKT: TPI), Pernix Therapeutics Holdings (NASDAQ: PTX) and Oculus Innovative Sciences Inc. (NASDAQ: OCLS). Free technical research on NVO, TPI, PTX and OCLS can be downloaded upon signing up at:

TPI Annual Meeting of Shareholders Announcement
PR Newswire - Wed Mar 26, 12:36AM CDT
Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) announced the time and location for its 2013 Annual Meeting of Shareholders.

3 Stocks Under $10 Making Big Moves
at The Street - Fri Mar 21, 5:00AM CDT
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

TPI Reports Second Quarter Fiscal Year 2014 Financial Results
PR Newswire - Thu Feb 13, 11:27PM CST
Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) announced financial results for the second quarter fiscal year 2014.

TPI to Host Second Quarter Fiscal Year 2014 Earnings Conference Call on Friday, February 14, 2014 at 9:00 a.m. ET
PR Newswire - Sun Feb 09, 12:56PM CST
Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API), today announced that the earnings conference call for the second quarter of fiscal year 2014 ended December 31, 2013 to be held at 9:00 a.m. ET on Friday, February 14th, 2014.

Ubiquiti inks distribution agreement with Ingram Micro
M2 - Thu Jan 16, 8:22AM CST
Ubiquiti Networks, Inc. (NASDAQ: UBNT) said it has announced a US distribution agreement with Ingram Micro Inc. (NYSE: IM).

TPI Reports First Quarter Fiscal Year 2014 Financial Results
PR Newswire - Fri Nov 15, 3:50AM CST
Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) announced financial results for the first quarter fiscal year 2014.

TPI to Host First Quarter Fiscal Year 2014 Earnings Conference Call on Friday, November 15, 2013 at 8:30 a.m. ET
PR Newswire - Mon Nov 11, 1:16AM CST
Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API), today announced that the earnings conference call for the first quarter of fiscal year 2014 ended September 30, 2013 to be held at 8:30 a.m. ET on Friday, November 15th, 2013.

TPI to Host Fiscal Year 2013 Earnings Conference Call on Friday, September 27th, 2013 at 9 a.m. ET
PR Newswire - Thu Sep 19, 4:00AM CDT
Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API), today announced that the earnings conference call for the fiscal year 2013 ending June 30, 2013 to be held at 9:00 a.m. ET on Friday, September 27th, 2013.

TPI Facility Received Official GMP Certificate
PR Newswire - Thu Sep 12, 9:32AM CDT
Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) today announced that the Company has received the Official Certificate of GMP for both of its pre-extraction plant and formulate facilities.

Penske completes $200M truck distributor deal
AP - Fri Aug 30, 9:48AM CDT
BLOOMFIELD HILLS, Mich. (AP) — Penske Automotive Group Inc. said Friday that it has completed its acquisition of a business that distributes trucks, spare parts and other services in Australia, New Zealand and in parts of Southeast Asia.

Tianyin Pharmaceutical Co Inc wins CFDA renewal status for TPI manufacturing facility in Longquan County
M2 - Fri Aug 16, 8:18AM CDT
Pharmaceutical company Tianyin Pharmaceutical Co Inc (NYSE Amex:TPI) revealed on Thursday that its its manufacturing facility has received GMP renewal status.

TPI Facility Received GMP Renewal by CFDA
PR Newswire - Thu Aug 15, 11:59AM CDT
Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) today provided the updates regarding TPI's manufacturing (pharmaceutical formulation) facility.

Penske Automotive to buy truck distributor
By The Associated Press - AP - Sun Jul 28, 6:50PM CDT
BLOOMFIELD HILLS, Mich. (AP) — Penske Automotive Group plans to buy a business that distributes trucks, spare parts and related services across Australia, New Zealand and Southeast Asia.

Tianyin Pharmaceutical Co Inc secures SFDA's approval for GMOL at Guangdong Province under PEDL status
M2 - Mon Jul 22, 8:07AM CDT
Pharmaceutical company Tianyin Pharmaceutical Co Inc (NYSE Amex:TPI) revealed on Friday that its flagship product Gingko Mihuan Oral Liquid (GMOL) has been awarded the SFDA's approval at the Guangdong Province, china.

GMOL Awarded Provincial Essential Drug List (PEDL) Status at Guangdong Province
PR Newswire - Fri Jul 19, 3:11AM CDT
Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) today provided further updates on the business development of its flagship product: Gingko Mihuan Oral Liquid (GMOL) with the SFDA approval number: H20013079.

TPI Corporate Presentation Updated Regarding Macrolide API Market
PR Newswire - Sun Jul 14, 7:01AM CDT
Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) today updated its corporate presentation with macrolide antibiotics API market information:

TPI's Qionglai Facility (QLF) Pre-extraction Plant Scheduled for GMP Inspection
PR Newswire - Tue Jul 02, 5:44AM CDT
Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) today provided the updates regarding TPI's Qionglai Facility (QLF).
Scroll down for more posts ▼

Top 10 Most Recent News Articles

CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 119

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 283

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 203

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 284

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 343

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 212

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 129

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 406

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 325

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 251

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
s?page=2">More News Articles